Page last updated: 2024-08-23

1-deoxynojirimycin and Diabetic Angiopathies

1-deoxynojirimycin has been researched along with Diabetic Angiopathies in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (33.33)29.6817
2010's2 (66.67)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Kim, SS; Koide, M; Nagasawa, Y; Sawada, T; Shiotani, H; Terashita, D; Yokoyama, M1
Adelman, MH; Monte, SV; Paladino, JA; Schentag, JJ1

Trials

1 trial(s) available for 1-deoxynojirimycin and Diabetic Angiopathies

ArticleYear
Comparison of effects of α-Glucosidase inhibitors and glinide drugs on endothelial dysfunction in diabetic patients with coronary artery disease.
    Circulation journal : official journal of the Japanese Circulation Society, 2014, Volume: 78, Issue:1

    Topics: 1-Deoxynojirimycin; Aged; Aged, 80 and over; Coronary Artery Disease; Cyclohexanes; Diabetic Angiopathies; Dyslipidemias; Endothelium, Vascular; Enzyme Inhibitors; Female; Glycoside Hydrolase Inhibitors; Humans; Hyperglycemia; Hypoglycemic Agents; Insulin Resistance; Lipids; Male; Middle Aged; Nateglinide; Phenylalanine

2014

Other Studies

2 other study(ies) available for 1-deoxynojirimycin and Diabetic Angiopathies

ArticleYear
Glucose supply and insulin demand dynamics of antidiabetic agents.
    Journal of diabetes science and technology, 2010, Mar-01, Volume: 4, Issue:2

    Topics: 1-Deoxynojirimycin; Acarbose; Cardiovascular Diseases; Diabetes Complications; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Dietary Carbohydrates; Energy Intake; Follow-Up Studies; Gluconeogenesis; Glucose; Glycated Hemoglobin; Heart Diseases; Homeostasis; Humans; Hypoglycemic Agents; Insulin; Intestinal Absorption; Liver; Metformin; Myocardial Infarction; Thiazolidinediones

2010
[Risk of complications in the diabetic patient. Postprandial blood glucose peaks as deciding factor].
    MMW Fortschritte der Medizin, 2000, Jul-06, Volume: 142, Issue:26-27

    Topics: 1-Deoxynojirimycin; Blood Glucose; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Glucosamine; Humans; Hypoglycemic Agents; Imino Pyranoses

2000